Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. new drug approvals slip in 2013 vs prior year
Yahoo/Reuters
Monday, December 30, 2013 - 5:34pm
tags:
FDA, drug approvals
Actavis' Women Health Biz Update
Yahoo/Zacks.com
Monday, December 30, 2013 - 5:33pm
tags:
Actavis, contraceptives, Women's Health, contraceptive rings, contraceptive patch
OphthaliX’s dry eye drug fails endpoint in Phase III study
Pharmaceutical Business Review
Monday, December 30, 2013 - 12:10pm
tags:
OphthaliX, dry eye disease, CF101
What Does the ViroPharma Buyout Mean for BioMarin?
Motley Fool
Monday, December 30, 2013 - 12:06pm
tags:
ViroPharma, M&A, Biomarin, Shire
OncoSec Medical Poised for Exciting 2014
Wall St Cheat Sheet
Monday, December 30, 2013 - 11:39am
tags:
OncoSec Medical, melanoma, skin cancer, immunotherapy
Myriad Genetics: How Low Can It Go?
Barron's
Monday, December 30, 2013 - 11:37am
tags:
Myriad Genetics, breast cancer, diagnostics
The Billion-Dollar Biotech Club: Speculation Trumped Risk
TheStreet.com
Monday, December 30, 2013 - 11:35am
tags:
biotech
FDA starts review of Cubist Pharma antibiotic
Yahoo/AP
Monday, December 30, 2013 - 11:33am
tags:
FDA, antibiotics, Cubist Pharmaceuticals, tedizolid
Dendreon: A Cautionary Tale For Biotech Investors
Wall St Cheat Sheet
Monday, December 30, 2013 - 11:32am
tags:
Dendreon, Provenge
Isis Pharmaceuticals, Inc. (ISIS): Strong Industry, Solid Earnings Estimates Revisions
Yahoo/Zacks.com
Monday, December 30, 2013 - 11:17am
tags:
Isis Pharmaceuticals
Sanofi MS Drug Lemtrada Fails to Win Backing of U.S. FDA
Bloomberg
Monday, December 30, 2013 - 11:16am
tags:
Sanofi, Lemtrada, FDA, MS, multiple sclerosis
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Monday, December 30, 2013 - 11:15am
tags:
Amgen, Acceleron, Celgene, anemia, sotatercept, ACE-536
Amarin: 3 Things Shareholders Should Demand In 2014
Seeking Alpha
Monday, December 30, 2013 - 11:12am
tags:
Amarin, Vascepa
Why Merck Is Planning to Change Its Research Strategy
Wall St Cheat Sheet
Monday, December 30, 2013 - 10:17am
tags:
Merck, R&D
2014 Looking Like A Big Year For Nektar
Seeking Alpha
Monday, December 30, 2013 - 10:16am
tags:
Nektar, NKTR-118, NKTR-102
The Best- And Worst-Performing Biotech Stocks, Dec. 19 to Dec. 26
Forbes
Monday, December 30, 2013 - 10:15am
tags:
biotech, Inovio, United Therapeutics, Synergy Pharmaceuticals
Johnson & Johnson: Great Product Portfolio But Not Cheap
Seeking Alpha
Monday, December 30, 2013 - 10:12am
tags:
JNJ
ANI Pharma buys generic drugs from Teva
Globes, Israel
Sunday, December 29, 2013 - 9:52am
tags:
ANI Pharmaceuticals, Teva, generics
Firm to seek 1st approval for stem cell-based medicine in Japan
The Japan News
Sunday, December 29, 2013 - 9:51am
tags:
stem cells, JCR Pharmaceutical, graft vs host disease
Abbott Labs settles with U.S. over kickback claims
Reuters
Saturday, December 28, 2013 - 10:10am
tags:
Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.